Physician Assistant · Atlanta, GA
NPI
1821107020
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1365 Clifton Rd NE
Atlanta, GA, 30322
Phone (404) 778-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
500 services
Medicare patients, 2024
285
Average age 72
Drug cost, 2024
$3.8M
777 prescriptions
Company payments, 2025
$32.19
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica J Neely was code 99214 (office e&m - established), 129 times for 76 patients. In total Jessica J Neely billed 500 services in 16 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 129 | 76 | $60.91 | $7,857 |
| 99213 Office E&M - Established | Office | 110 | 74 | $37.56 | $4,132 |
| 38222 Other Organ Systems | Facility | 97 | 96 | $46.50 | $4,511 |
| 99213 Office E&M - Established | Facility | 59 | 20 | $37.67 | $2,223 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 24 | $52.03 | $1,457 |
| 99233 Hospital E&M - Subsequent | Facility | 23 | 21 | $77.73 | $1,788 |
By year: 2022 $23K for 538 services; 2023 $22K for 520 services; 2024 $25K for 500 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica J Neely prescribed most often to Medicare patients was Hydroxyurea, with 158 prescriptions and refills. In total Jessica J Neely wrote 777 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 158 | 385 | 51 | $5,230 |
| Jakafi Ruxolitinib Phosphate | 89 | 89 | 14 | $1.5M |
| Imbruvica Ibrutinib | 45 | 45 | Under 11 | $662K |
| Pegasys Peginterferon Alfa-2a | 36 | 36 | Under 11 | $150K |
| Sprycel Dasatinib | 31 | 31 | Under 11 | $495K |
| Allopurinol Generic | 24 | 52 | 11 | $170 |
| Valacyclovir Valacyclovir Hcl | 22 | 40 | 12 | $450 |
| Gabapentin Generic | 19 | 19 | Under 11 | $64.13 |
| Prochlorperazine Maleate Generic | 17 | 17 | Under 11 | $265 |
| Ondansetron Hcl Generic | 17 | 17 | Under 11 | $26.66 |
| Xarelto Rivaroxaban | 14 | 34 | Under 11 | $20K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 13 | 13 | Under 11 | $266 |
| Eliquis Apixaban | 13 | 39 | Under 11 | $22K |
| Besremi Ropeginterferon Alfa-2b-Njft | 12 | 12 | Under 11 | $198K |
Brand drugs: - claims; generic drugs: 493 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica J Neely $32.19 ($32.19 in general payments such as food, travel and fees) from 1 company. The largest payer was Adaptive Biotechnologies Corporation with $32.19.
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation ADPT | 1 | $32.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.